Management of severe COPD.
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide, and the burden of the disorder will continue to increase over the next 20 years despite medical intervention. Apart from smoking cessation, no approach or agent affects the rate of decline in lung function and progression of the disease. Especially in the later phase, COPD is a multicomponent disorder, and various integrated intervention strategies are needed as part of the optimum management programme. This seminar describes largely non-pharmacological interventions aimed at improving health status and function of disabled patients. Exacerbations become progressively more troublesome as baseline lung function declines, commonly necessitating hospital admission and associated with the development of acute respiratory failure.
Wouters
E F M
EF
Department of Respiratory Medicine, University Hospital Maastricht, 6229 HX Maastricht, Netherlands. e.wouters@lung.azm.nl
D000208:Acute Disease; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D004487:Edema / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D016040:Lung Transplantation; D011013:Pneumonectomy; D011379:Prognosis; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D012121:Respiration, Artificial / Q000379:methods; D012131:Respiratory Insufficiency / Q000209:etiology / Q000628:therapy; D014883:Water-Electrolyte Imbalance / Q000209:etiology / Q000503:physiopathology; D015431:Weight Loss
D000318:Adrenergic beta-Agonists